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Tendon injuries pose a great clinical challenge to orthopedic surgeons. Over 
200,000 patients undergo tendon repair every year in the United States alone. The role of 
progression of a tendon injury is multifactorial as a lot of factors come into play during 
and after the injury at various phases of healing process. There is a still a vast 
requirement for thorough elucidation and understanding of the pathophysiology and the 
factors involved in the progression of tendon injury. Although the degenerative role of 
several MMPs and ADAMTs have been reported, yet there is very less information on 
the actual role and function of the various types of collagen in tendons and their response 
to the above factors, particularly after an injury and during the healing and repair phases. 
Our results indicate that there is a lot of variability in the levels of collagen types I, III 
and V in relation to the age of the animal, injury and the healing period. This might not 
be any surprising as the fluctuation in the levels indicate that there might be a different 
mechanisms involved in progression and healing of the injuries in young and old rabbits, 
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In the simplest description, tendons are tough belt like strips of fibrous connective 
tissue consisting of collagen fibers, which bridge a bone with a skeletal muscle (Figure 
1). Their predominant activity is to limit, confine, absorb, withstand tension and to 
transmit the forces from the skeletal muscle to the bone1. The higher the force generated 
by the muscle, the more stress 
transmission takes place 
through the tendon2. Tendons 
are white to pale colored 
anatomical structures present 
connecting muscles to bones3. 
They offer resistance to 
mechanical loads4, and aid in 
joint movement, serving as 
rigid and stable fibro-elastic 
structures and conveying the 
muscular contraction forces 
with the least possible energy 
scattering5,6. 
 
FIGURE 1: Drawing of a tendon bridging the calf muscle 
with the heel. Adapted from Gray's Anatomy. 
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1.2 Composition of tendons: 
Tenoblasts are the primary cells in tendons. More than 90% (90-95%) of the tendon’s 
cells are tenoblasts4,7. A tenocyte is a less metabolically active form of a tenoblast8. In 
comparison with tenocyte, tenoblasts have a larger rough endoplasmic reticulum, a well-
organized mature Golgi-apparatus and an increased number of mitochondria. These 
important phenotypic differences are required in order to synthesize and secrete collagen 
fibers, ground substance, cytokines, enzymes, and other proteins necessary for the 
uninterrupted generation of extracellular components9,10. The other major components of 
mammalian tendons include extracellular collagen fibrils enclosed in a proteoglycan/ 
water extracellular matrix4,7,11-13. The tendon is a perfect example of a remarkably 
structured extracellular matrix where-in the molecular chains of collagen protein cluster 
into filamentous collagen fibrils, constituted by microfibrils14-18 which package together 
to make up the main structural components i.e. collagen fibers12,19-21. The main 
extracellular component in tendons are collagen fibers and they make up 70-80% of the 
dry weight 9,22,23 and 30% of the wet weight22. In the extracellular matrix, the larger part 
(95%) is constituted by the presence of type I collagen, nonetheless, 5% of mature adult 
tendon also has some of other types of collagen, of which type III and type V are 
prominently observed24. The total dry weight of the tendon is comprised of 70-80% of 
collagen I and the rest 20 to 30% of other minor collagens along with proteoglycans, 
glycolipids, elastin and matrix25-27.  
Ground substance is also synthesized by tenoblasts and serves as a vehicle 
through which the gases, nutrients, minerals and metabolic by-products are diffused from 
the active tenoblasts22. It is a viscous watery and jelly-like liquid comprised of 
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glycosaminoglycans, proteoglycans and glycoproteins [9]. Glycosaminoglycans are the 
straight chain polysaccharides grouped by a continuous sub-units of disaccharides8,9. 
These include chondroitin-6 and dermatan sulphate9. These are highly hydrophilic, and 
despite these accounting for only 1% of the dry weight, they combine with water and 
make up to 65-75% of the wet weight of the tendon23. Proteoglycans include a larger 
amount of decorin28,29, and also smaller amounts of hyaluronan, biglycan, fibromodulin, 
lumican, epiphycan and keratocan30,31 and are joined to the collagen fibers in orthogonal 
fashion. These make up less than 1% of the dry weight of tendon32. Glycosaminoglycans 
and proteoglycans together determine the thickness of the collagen fibril and also control 
the inter-fibrillar and inter-fiber space9. Fibronectin is the predominant glycoprotein and 
aids in the attachment of tenoblasts to the collagen fibers22. Elastin is the other fiber type 
which includes for just 1-2% of the dry weight4, under 2% of the wet weight and plays a 
vital role in maintaining the elasticity of the tendon22. 
 
1.3 Structural Organization of Tendon 
The predominant extracellular building block of tendons is collagen and is the protein 
most abundantly present in mammalians33,34. Tropocollagen is the structural unit of 
collagen22. The precursor of tropocollagen is procollagen. Tropocollagen is synthesized 
when the non-helical N- and C- terminal propeptide units from procollagen molecule are 
cleaved enzymatically by matrix metalloproteinase C- proteinase and N- proteinase after 
it comes out from the tenoblast22,35. Each tropocollagen molecule is characterized by the 
presence of three helically ordered polypeptide chains of alpha chains9. Amino acid 
residues make up the poly peptide chains. Tropocollagen has a glycine amino acid 
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residue at every third position9,22. The other main amino acid residues of the alpha chains 
include proline (12%), hydroxyproline (10%), lysine and hydroxylysine9,22. A group of 
four to five tropocollagen molecules join together to form collagen microfibrils9,23,36. 
These and aggregate to form a collagen fibril37. Fibrils again group to form parallel 
fibers, which further aggregate to form fascicles38. Some of the tendons are covered by a 
loose connective tissue sheath known as the para-tenon. It predominantly consists of 
collagen I and collagen III fibrils39. Beneath the para-tenon is the epi-tenon, made of fine 
connective tissue. The collagen fibers are again covered by loose areolar connective 
tissue sheaths, at various levels of hierarchy40. There is also the presence of endo-tenon 
under the epitenon which carries blood vessels, lymph vessels and nerves to the inner 
areas of the tendon23,41. 
FIGURE 2: Organization of a Collagen Fibril, Adapted from Peter A et al, “Tendon 




FIGURE 3: Various diagrammatic representations of the Structural Organization of Tendon 
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1.4 Tendon Injuries 
Tendon injuries pose a great clinical challenge to orthopaedic surgeons42. Over 
200,000 patients undergo tendon repair every year in the United States alone43. Overuse 
tendon injuries are approximated to be responsible for more than 30 to 50% of the sports 
linked injuries in the US38,44. Overuse tendon injuries along with tendinopathies serve as 
a source for approximately 7% of all injury associated doctor visits in the US45.  
1.5 Etiology of tendon injuries 
The basic mechanism underlying a tendon injury is simply explained by the 
development a rupture in the tendon followed by disarrangement of collagen fibrils 
leading to its failure. This teardown primarily happens due to the overall increase in the 
stress limit or mechanical load on the tendon, due to increasing age44,46 or overuse23. 
Chronic tendon injury develops due to failure in the healing of initially occurred ruptures, 
and the rate of healing to be far less when compared to the rate of accruing new injuries 
over time, which may be due to lack of rest or overuse23. The tendon injury primarily 
originates because of the action of increased forces on the tendon, which are far greater 
than the limit which it is designed to effectively withstand, combat and compensate for10. 
In addition, the tendon might undergo structural, cellular or molecular transformations, 
due to genetic disorders, vascular modifications, endocrine effects like hormonal 
imbalances, deficiencies in nutrition, inactivity, immobilization and exercise related 
causes, which ultimately progress towards injury even due to the action of normal 
forces22,23,44,46-48. Even antibiotics like fluoroquinolones are shown to induce apoptosis49, 
oxidative damages50 and breakdown of collagen i.e. collagenolysis51 in tendon.  
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1.6 Pathophysiology of tendon injury: 
Tendon overuse causes the release of pro-inflammatory mediators52, which in-turn 
stimulate metalloproteinases, leading to collagenolysis ultimately51,53. The 
histopathological characterization of tendon injuries have depicted disarranged collagen 
fibril organization and alignment along with an increase in the content of proteoglycan, 
ground substance and neovascularization (figures x and y)54,55. The levels of collagen I 
and III were also found to be increased in the matrix. Collagen V is involved in the 
regulation of collagen I diameter during the fibrillogenesis56,57. The levels of collagen V 
were also found to increase during healing, and this increased level of collagen V might 
help the synthesis of smaller collagen I fibrils, and ultimately lead to decrease in 
mechanical strength57,58. The levels of fibronectin, Tenacin C were also found to be 
increased. Glycosaminoglycans were also found to be on the higher side in injured 
tendons51,59. 
1.7 Tendon Injury Healing: 
The healing process of tendon injury can be explained in three distinct yet mutually 
coinciding processes. The inflammatory stage, the repair stage and then the remodelling 
phase60. Initially, different cells like erythrocytes and neutrophils approach the site of 
injury and secrete vasoactive and chemotactic factors, which cause the tenoblasts to 
actively proliferate and move to the site and start the repair process. These tenoblasts 
synthesize large amounts of collagen and other constituents of extracellular matrix which 






MATERIALS AND METHODS 
 
2.1 Animals: 
Rabbits 1 year (young) and 4 year (old) had full length patellar tendon injuries 
created in the middle 3rd of the tendon. Tendon injuries were made on one side and the 
contralateral tendon was used as an unoperated control. They were allowed to heal for 6, 
12 and 26 weeks and later harvested for analysis of the proximal, distal and middle 
portion of the tendon. The tissues were stored at -80 until extraction and analysis. 
2.2 Methods: 
2.2.1 Extraction of the collagens I, III and V from the tissues – Method 
development. 
Collagen was extracted from the tissues using both acid and enzyme soluble 
extraction methods61. In order to extract the maximal amounts of the types of collagen 
from the tissues, these two methods were combined. The procedure mainly included the 
extraction of ground tendon tissue in organic acid (0.5M СН3СООН) in the presence of 
5mM EDTA and pepsin with concentration of 0.0025 mg per 5 mg of tissue, pH = 2.5-
3.0 for 48 -96 h at 4°C. The collagen isolation was carried out in the following steps: 
Initially, the ground tissue pieces were washed thoroughly with distilled water.  This was 
followed by washing with 0.05M Na2HPO4, at pH 8.7 – 9.1 at 4°C so as to extract the 
non-collagenous proteins. The tissue was then dissolved in 0.5M CH3COOH with 5mM 
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EDTA. Pepsin was then added directly into the solution of collagen in acetic acid at a 
ratio of 50 mg of pepsin per 1g of tendons, at 4°C. Addition of pepsin was repeated once 
more after 12 hours.  
The entire procedure was repeated 3 times and each time, the supernatants of the 
extracted solutions were collected after centrifugation at 3000 X g for 45 min at 4°C.  
The three extracts were combined and the collagen salted out by adding NaCl at an initial 
concentration of 0.8M and then increasing to a final concentration of 4M62, so as to 
precipitate each of the three collagen types (I, III and V). The obtained precipitate 
contained collagen that was dissolved in 400 l of 1M acetic acid. Then the solution was 
finally dialyzed against 0.02M Na2HPO4 for 72 hours at 4°C to remove the salt. The 
dialysis solution was changed every 24 hours. 
2.2.2 Determination of the total collagen by modified Bradford assay 
The collagen extracts were then analyzed for determining the total collagen content. 
For this, the modified Bradford assay was employed which more accurately detects the 
amount of collagen in the solution63,64. Bradford reagent was initially diluted four fold 
with water and 0.0035% of SDS was added to it. The Bradford assay was carried out, and 
the plates were read at 380nm on the Spectramax Plus 384 UV/VIS spectrophotometer 
(Molecular devices, Sunnyvale, CA) and the concentrations of the extracted proteins 
were calculated. 
2.2.3 Poly-Acrylamide Gel Electrophoresis 
Native PAGE:  To detect collagen I, V and actin in western blotting, native PAGE 
was performed. Non-denaturing and non-reducing conditions were employed so as to 
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maintain the original fold and confirmation of the proteins in the samples. The samples 
with equal amount of protein were mixed with equal amounts of native loading buffer 
and then, loaded and separated on Criterion Tris HCL 10% – 20% precast gels. 
SDS – PAGE: SDS-PAGE was performed to detect collagen III in western blotting. 
The samples with equal amount of protein were mixed with equal amounts of Laemmli 
sample buffer and heated at 95°C in water bath for 7 minutes. Denaturing and reducing 
conditions were followed. The samples were then loaded and run on Criterion Tris HCL 
10% – 20% precast gels. 
2.2.4 Western Blotting 
The proteins were then transferred overnight to PVDF membranes and then blocked 
in 3% non-fat dry milk in 1X PBS containing 0.3% Tween 20 for an hour and washed 
subsequently with the wash buffer (1X PBS containing 0.3% Tween 20).  They were then 
incubated in the primary antibody (Collagen I, III, V and actin) at a dilution of 1:500, for 
about an hour. The membranes were then washed for 15 minutes and incubated with 
HRP-conjugated anti mouse secondary antibody for an hour. The membranes were finally 
washed for 15 minutes and incubated in the West-Femto substrate and imaged on Bio-
Rad Chemidoc MP imaging system using image-lab software. 
2.2.5 Band densitometry:  
The band density corresponding to each of collagen I, III, V and actin were quantified 
using the image-lab software, and later the levels of Collagen I, III and V were 




2.2.6 Statistical analysis 
Statistica 10.0 was used for the statistical analysis of the data. All data were expressed 
as mean ± SD (Standard deviations), and the statistical differences among different 
groups were assessed by one-way ANOVA. Tukeys post hoc test was used for comparing 
three groups. The level of significance was considered as P < 0.05 which indicated a 





















3.1 Development of procedure for extracting collagen from tendons.  
The main goal of this project was to compare types of collagen from tendons 
following damage. To achieve this goal, we first needed to develp a method for extracting 
the collagen from the tendons. Collagen is a very insoluble protein complex that is 
difficult to extract and work with, therefore, we spent some time to learn and adapt 
previously described protocols61,62,65,66. In figure 4, we show that the protocol required 





FIGURE 4: Protocol for extraction of Collagen type I, III and V from Rabbit tendons, 
Adapted from Mocan et al, “Aspects of Collagen Isolation Procedure”. 
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From this protocol we were able to observe multiple bands putatively identified as 
collagen on a coomassie stained gel (Figure 5). The number of bands suggested that 
collagen was not the only protein extracted.  
 
FIGURE 5: Denaturing SDS-PAGE of Collagen Extraction from 4 tendon samples. 
The coomassie stained gel was loaded with standard marker (Bio-Rad) in lanes 1 and 6. 
Lanes 2-5 contained an aliquot of proteins extracted from four different tendons as 
described above.  
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To analyze these gels further, western blots were probed for collagen I, III, V and actin 
were  (figure 6).  
 The following are the images of the western blot. The bands were seen at 42 kda 
for actin, at 45 kda for collagens I, III and V. 
1. Collagen I 
 
 


















3.2 Levels of collagen I, III and V in control and open rabbits 
 
3.2.1 Levels of Collagen I, III and V in young rabbits. 
The first analysis was to determine if the age of the rabbit had an effect on the 
type of collagen expressed in the wound. In young rabbits, at 6 weeks of healing, the 
levels of collagen I III, and V were not significantly different in control rabbits compared 
to open rabbits (Figure 7).  
 
FIGURE 7: Levels of Collagen I, III and V in young control rabbits vs young open 
rabbits at 6 weeks of healing. The bars represent the mean ± SD values of normalized 
levels of Collagen I, III and V in young control (green) and in young open (yellow) 
rabbits at 6 weeks of healing. In young rabbits, at 6 weeks of healing, the levels of collagen I, 
III and V were not significantly different in open rabbits compared to control rabbits.  
 
By western blot, the ratio of I:III:V appeared to be ~3:1:1 in controls and 2:1:0.4 
in Open. However, at 12 weeks of healing, there was still no significant change in the 
types of collagens III and V, though there was a slight 1.4 fold increase in collagen I in 
open which was significant (Figure 8). In contrast to 6 weeks, there appeared to be no 
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difference in the ratios of any of the collagens with each being ~1:1:1, representative of a 
decrease in collagen I (Figure 8). At 26 weeks, there was no difference in open or control 
levels of collagen I and V, but there was a significant decrease in the levels of collagen 
III (Figure 9) in the open compared to control. Also, the overall levels were considerably 
lower. However, there did appear to be a significant decrease in the ratio of collagen I to 
III, i.e., ~0.67% (Figure 9). 
 
FIGURE 8: Levels of Collagen I, III and V in young control rabbits vs young open 
rabbits at 12 weeks of healing. The bars represent the mean ± SD values of normalized 
levels of Collagen I, III and V in young control (green) and in young open (yellow) 
rabbits at 12 weeks of healing. In young rabbits, at 12 weeks of healing, the levels of collagen I 
were significantly higher (indicated by *, P < 0.05, N = 18, n (control) = 9, n (open) = 9)) in open 





FIGURE 9: Levels of Collagen I, III and V in young control rabbits vs young open 
rabbits at 26 weeks of healing. The bars represent the mean ± SD values of normalized 
levels of Collagen I, III and V in young control (green) and in young open (yellow) 
rabbits at 26 weeks of healing. In young rabbits, at 26 weeks of healing, the levels of collagen 
III were significantly higher (indicated by *, P < 0.05, N = 32, n (control) = 18, n (open) = 14)) in 
open rabbits compared to control rabbits. The levels of collagen III and V were not significantly 
different.  
 
When each collagen from the Young Open was compared between 6, 12 and 26 
weeks, the levels of collagen I appeared to show a significant decrease at 26 weeks 
compared to 6 weeks and 12 weeks, while the levels of collagen III appear to be 
increased at 12 followed by a significant decrease at 26 weeks compared to 12 weeks.  
Collagen V showed a significant increase at 12 compared to 6 weeks followed by a 
decrease to nearly the same 6 week levels (Figure 10). In control animals, there was a 






FIGURE 10: Levels of Collagen I, III and V in young open rabbits at 6, 12 and 26 
weeks of healing. The bars represent the mean ± SD values of normalized levels of 
Collagen I, III and V in young open rabbits at 6 weeks (red), 12 weeks (green) and 26 
weeks (yellow) of healing. In young open rabbits, the levels of collagen I were significantly 
lower at 26 weeks compared to the levels at 6 weeks (P < 0.05, N = 23, n (26 weeks) = 14, n (6 
weeks) = 9) and the levels at 12 weeks (P < 0.05, N = 23, n (26 weeks) = 14, n (12 weeks) = 9)). 
The levels of collagen III were significantly lower at 26 weeks compared to the levels at 12 
weeks (P < 0.05, N = 23, n (26 weeks) = 14, n (12 weeks) = 9). The levels of collagen V were 
significantly higher at 12 weeks compared to the levels at 6 weeks (P < 0.05, N = 18, n (12 
weeks) = 9, n (6 weeks) = 9) and significantly lower at 26 weeks compared to the levels at 12 
weeks (P < 0.05, N = 23, n (26 weeks) = 14, n (12 weeks) = 9)) 
 
3.2.2 Levels of Collagen I, III and V in Old Rabbits. 
The levels of collagen, I, III, and V were analyzed in tendons from older rabbits, 
i.e., at 4 years of age. In old rabbits, at 6 weeks of healing, the levels of collagen I, III, 
and V were no different in control rabbits compared to open rabbits (Figure 11). There 
appeared to be a difference between control and open for both collagen I and III, though 











I, III, and V were found to be the same between control and open. The ratio of collagen I 
to III to V were also the same for both open and control (Figure 12).  
FIGURE 11: Levels of Collagen I, III and V in old control rabbits vs old open 
rabbits at 6 weeks of healing. The bars represent the mean ± SD values of normalized 
levels of Collagen I, III and V in old control (green) and in old open (yellow) rabbits at 6 
weeks of healing. In old rabbits, at 6 weeks of healing, the levels of collagen I, III and V were 
not significantly different in open rabbits compared to control rabbits.  
 
FIGURE 12: Levels of Collagen I, III and V in old control rabbits vs old open 
rabbits at 12 weeks of healing. The bars represent the mean ± SD values of normalized 
levels of Collagen I, III and V in old control (green) and in old open (yellow) rabbits at 
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12 weeks of healing. In old rabbits, at 12 weeks of healing, the levels of collagen I, III and V 
were not significantly different in open rabbits compared to control rabbits.  
 
FIGURE 13: Levels of Collagen I, III and V in old control rabbits vs old open 
rabbits at 26 weeks of healing. The bars represent the mean ± SD values of normalized 
levels of Collagen I, III and V in old control (green) and in old open (yellow) rabbits at 
26 weeks of healing. In young rabbits, at 26 weeks of healing, the levels of collagen I were 
significantly higher (indicated by *, P < 0.05, N = 10, n (control) = 6, n (open) = 4)) in open 
rabbits compared to control rabbits. The levels of collagen III and V were not significantly 
different. 
At 26 weeks, the levels of collagen I appeared to be significantly different but not 
in III or V (Figure 13). The ratios of collagen I:III:V were shifted in these to a 1:1:0.3 for 
controls and 1:1:0 for open, suggesting decrease in collagen V with age (Figure 13).  
When the age of the rabbits was taken into consideration, there appeared to be 
significant shifts in collagen production in open rabbits, especially collagen III and V 
(Figure 13). Most notably, there was a significant increase in each of these at 12 weeks, 






FIGURE 14: Levels of Collagen I, III and V in old open rabbits at 6, 12 and 26 
weeks of healing. In old open rabbits, the levels of collagen I were significantly higher at 12 
weeks compared to the levels at 6 weeks (P < 0.05, N = 27, n (12 weeks) = 15, n (6 weeks) = 12). 
The levels of collagen III were significantly higher at 12 weeks compared to the levels at 6 weeks 
(P < 0.05, N = 27, n (12 weeks) = 15, n (6 weeks) = 12). The levels of collagen V were 
significantly higher at 12 weeks compared to the levels at 6 weeks (P < 0.05, N = 27, n (12 
weeks) = 15, n (6 weeks) = 12) and significantly lower at 26 weeks compared to the levels at 12 






















After the development of tenocytes, i.e. the tendon progenitor cells, they aggregate to 
form characteristic tendon units and initiate the synthesis of collagenous matrix as small diameter 
fibrils67. This is the initial phase of hierarchical association of collagen, and is called 
fibrillogenesis68. This fibrillogenesis lasts on and progresses after birth, with the aggregation of 
collagen I molecules, leading to lateral and linear growth24. Thus the collagen molecules 
aggregate in a three step process to form the hierarchical structure of tendon. Collagen I, III and 
V are the major fiber forming collagens69. The collagen molecules initially aggregate to form 
immature fibril intermediates. These collagen fibril intermediates then join end to end to produce 
longer fibrils. Finally the lateral association takes place to increase the diameter of the fibril70. 
These two processes lead to a varying distribution of fibril diameters in adult tendons. Recent 
evidence suggests collagen – collagen interactions produce and regulate the architecture of the 
fibrils and/or fibers69. This is due to the association of collagen I and III71, I and V72, and I, III, 
V73. Collagen III is found to have a role in the initiation of fibril assembly74and also affects the 
linear growth of the fibrils and causes less fibrillar organization75. The association of collagen V 
with collagen I results in smaller fibril size57,58. This co-assembling explains the mechanism of 
regulation in the diameter and linear length of the fibers, which further characterize the 
mechanical strength of the tendon69. 
It is already established that the levels of collagen I and III increase during tendon 
healing, but there is no information on the activity of collagen V56,57. Our experiments were 
designed primarily to identify the levels of collagen I, III and V in comparison to control (normal) 
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and injured (open) tendons. The injured tendons were allowed to heal naturally without any 
pharmacological intervention for a period of 6, 12 and 26 weeks.  
The decreased levels of collagen I and V in open young rabbits at 6 weeks of healing 
might be primarily due to the injury and pathogenesis. As the injury begins to heal new collagen 
molecules would be synthesized by the tenocytes so as to repair and rebuild the injured tissue. 
The levels of collagen I and III start to increase at 12 weeks and the levels of collagen V decrease. 
Collagen III is found to have a role in the initiation of fibril assembly74, and hence, the levels of 
collagen III should be increased so as to favor the synthesis of new collagen fibers. As the new 
fibrils had formed, the levels of collagen III begin to decrease. The decrease in the levels of 
collagen V might be explained in young rabbits, as its association with collagen I results in 
smaller fibril size57,58. This ultimately suggests that there would be a better healing response in 
younger rabbits, due to the decrease in levels of collagen V, which causes no reduction in the 
length and diameter of collagen fibrils. 
The decrease in levels of collagen I and III in old open rabbits at 6 weeks suggests the 
changes following the injury. The levels of collagen I, III and V start to increase in old open 
rabbits at 12 weeks. Collagen V levels decline at 26 weeks again. The increase in collagen I and 
III in old rabbits suggests a slow healing response as collagen III is associated post-injury 
fibrillogenesis74,76. The decrease in the levels of collagen V suggest the tissue adaptation to 
prevent the formation of small collagen fibrils as collagen V is associated with formation of 
smaller fibrils57,58. 
In open rabbits, the increased levels of collagen III in old rabbits compared to young 
suggest a delayed and ongoing fibrillogenesis and hence forth the delayed healing process. In 
open young as well as old rabbits, the increase in levels of collagen III and V at 12 weeks 
followed by a decrease at 26 weeks suggest us of the initiation of fibrillogenesis and a healing 
response, which is similar in both. The decrease in the level of collagen I is surprising though. 
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This unusual pattern in the decreasing levels of collagen I and III that totally differs and 
contradicts with earlier studies can be possibly due to their degradation due to prolonged storage 
of the harvested tissues. Additional bands were visualized in the western blots which were not 
accounted for, and possibly might be degradation products.  
The differences in the levels of collagen in old rabbits can also be partially attributed to 
their poor solubility due to the Amadori re-arrangement leading to the formation of AGEs i.e 
advanced glycation end products like pentosidine77-79. This could decrease the solubility of 
collagen in acetic acid during our initial extraction, and might have caused to an overall lower 
level of extracted collagen.  
The wide variability in the levels of collagen in control rabbits suggest us of the fact that 
there is a continuous remodeling of the tendon matrix, due to the activity of matrix 
metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs 
(ADAMTs), transforming growth factor- β (TGF- β) which is associated with the production of 
collagen, influence the proteoglycans as well as collagen80,81. This might also due to the increased 
mechanical load on the tendon because of the normal functioning of only one of the legs, the 
















The following are some of the limitations associated with the extraction 
procedure followed for quantifying the collagen types I, III and V. 
Although the protocol followed for the extraction of the collagen is believed to 
extract all the three types of collagen i.e. I, III and V, the corresponding bands for the 
collagen types I, III and V in the western blots did not appear at their respective predicted 
sizes. The actual predicted bands of collagen I, III, and V were reported at 130, 135, and 
185 kilodaltons daltons respectively83-85. But the bands which were visualized in our 
study were around 45 kilodaltons. The protocol followed for the extraction of the 
collagen types I, III and V needs to be further tested on pure samples of collagen I, III 
and V individually and together so as to identify the corresponding control bands for the 
collagen types I, III and V. By this, the collagen I, III and V controls can be compared 
with the extracted samples of collagen I, III and V, and thereby the variation in the 
molecular weights of these can be identified. 
The collagen type I content is expected to be ~90-95% of the total collagen 
content, and the collagen III and V account for approximately less than 10% of the total25-
27. In our study, there appeared to be almost identical proportions of all of the three types 
of collagen extracted. This might be due to the differences in the extraction levels of 
collagen I, III and V. The amount of the type of collagen extracted is of debate as there 
might be a chance that the extraction of collagen I was more efficient compared to types 
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III and V. This is because the protocol was primarily designed to extract collagen type I, 
and was optimized to extract the other minor collagens too. Collagens I and V were 
precipitated by a salt concentration of 0.8 M and III was precipitated at 4 M salt 
concentration. This differential precipitation might have led to differences in the levels of 
extraction of the collagens I, III and V. Since we did not run a standard curve for the 
western blots, or an ELISA, the amount cannot be accurately determined. In addition, the 
antibodies used might have been more sensitive for one type over the others. Again, these 
problems could result in a skewed relative determination.  
The structure of collagens I, III and V are very similar to each other, having a 
high number of glycine, arginine, and proline residues, and hence a specific antibody for 
a particular type of collagen might have cross reactivity with another. The antibodies that 
we used to detect the collagens I, III and V were purchased to be specific to the type of 
collagen but the cross reactivity cannot be ruled out completely. So, the bands which 
appeared at 45 kilodaltons for all of the collagens I, III and V might be due to non-
specific immunostaining. Alternatively, it is possible that there could be a subunit of 
collagen that is cleaved to 45 kDa, and which may be similar in all three types of 
collagen. While the pepsin used in the experiment is not supposed to cleave collagen, it 
might contain impurities that cause non-specific cleavage. Testing with pure collagen 
would give us answers to this question.  
Furthermore, it is difficult to identify and quantitate the collagens effectively in 
tissues like tendons. As there is a lack of a reliable method to accurately identify and 
quantify full-length collagen molecules. Therefore, mass spectrometric analysis might 
help to achieve better characterization of the collagen types I, III and V, such that these 
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can be quantified accordingly. The problem is that even then, there might be so much 
overlap in sequence that specific regions might not be isolated and adequately identified. 
This has been particularly difficult in past studies and we did not have success during the 
course of this project. One problem with the digestion of the collagen is that the types of 
enzymes used to remove other proteins and glycosylation etc, could have been impure 
and caused non-specific cleavage.  
The tendon tissues were dissected and excised after the treatment. There is a 
possibility that dissection of the surrounding tissue which might not be the actual 
damaged tendon tissue, but rather the undamaged surrounding tissue. This inclusion of 
the surrounding tissue could lead to a skewed presence of a particular type of collagen 
over another and explain the wide variability in the levels of collagen I, III and V. 
Likewise, since the injured tendon was compared with the uninjured tendon from the 
opposite leg, there may have been some compensation in the other leg and lack of use in 
the injured, causing a non-standard healing to occur.  
The thermal denaturation of collagen results in the formation of gelatin 
molecules86. The tendon tissues used for this study were stored in the freezer for more 
than a decade. There may have been improper storage of the tendons or a thaw on the 
tissue at some point, which could have compromised its integrity. While this is thought to 













Our results indicate that there is a lot of variability in the levels of collagen types I, III 
and V in relation to the age of the animal, injury and the healing period. However, there is no 
difference in the healing patterns of young and old rabbits. Yet, a reliable method for quantifying 
and analyzing the different types of collagen in tendons needs to be developed so as to unravel 
the various pathophysiological events and healing responses occurring in the tendons, for which 
the types of collagen are thought to be responsible and accounted for.  
The fluctuation in the levels indicate that there might be a different mechanisms involved 
in progression and healing of the injuries in young and old rabbits. Also there might be various 
other factors which come into play like the MMPs and ADAMTs, during the various phases of 
healing which explains the wide differences in the collagen levels at different healing points.  
The role of progression of a tendon injury is multifactorial as many pathways and 
processes come into play during and after the injury at various phases of healing process. There is 
a still a vast requirement for thorough elucidation and understanding of the pathophysiology and 
the factors involved in the tendon injury. Although the degenerative role of several MMPs and 
ADAMTs have been reported, yet there is very less information on the actual role and function of 
the various types of collagen in tendons and their response to the above factors, particularly 
during the healing and repair phases. Future work needs to be targeted on the identification and 
characterization of all the types of collagen present and involved during the pathogenesis, as well 
as in healing, repair and regenerative phases of tendinopathy. This information can be used to 
clearly understand and well establish the pathophysiology of tendinopathy, can lead to better 
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prognostic approach and help to device an effective pharmacological strategy so as to treat the 





























APPENDIX - I 
List of Samples and their corresponding Tissues 
Sample Label Tissue No Age Treatment Weeks Tendon Type 
1 58 Old Control 6 Weeks Patellar 
2 58 Old Control 6 Weeks Medial 
3 58 Old Control 6 Weeks Tibial 
4 58 Old Open 6 Weeks Patellar 
5 58 Old Open 6 Weeks Medial 
6 58 Old Open 6 Weeks Tibial 
7 59 Old Open 6 Weeks Patellar 
8 59 Old Open 6 Weeks Medial 
9 59 Old Open 6 Weeks Tibial 
10 59 Old Control 6 Weeks Patellar 
11 59 Old Control 6 Weeks Medial 
12 59 Old Control 6 Weeks Tibial 
13 60 Old Control 6 Weeks Patellar 
14 60 Old Control 6 Weeks Medial 
15 60 Old Control 6 Weeks Tibial 
16 60 Old Open 6 Weeks Patellar 
17 60 Old Open 6 Weeks Medial 
18 60 Old Open 6 Weeks Tibial 
19 62 Young Open 6 Weeks Patellar 
20 62 Young Open 6 Weeks Medial 
21 62 Young Open 6 Weeks Tibial 
22 62 Young Control 6 Weeks Patellar 
23 62 Young Control 6 Weeks Medial 
24 62 Young Control 6 Weeks Tibial 
25 490 Old Control 6 Weeks Patellar 
26 490 Old Control 6 Weeks Medial 
27 490 Old Control 6 Weeks Tibial 
28 490 Old Open 6 Weeks Patellar 
29 490 Old Open 6 Weeks Medial 
30 490 Old Open 6 Weeks Tibial 
31 1461 Young Control 6 Weeks Patellar 
32 1461 Young Control 6 Weeks Medial 
33 1461 Young Control 6 Weeks Tibial 
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34 1461 Young Open 6 Weeks Patellar 
35 1461 Young Open 6 Weeks Medial 
36 1461 Young Open 6 Weeks Tibial 
37 1462 Young Open 6 Weeks Patellar 
38 1462 Young Open 6 Weeks Medial 
39 1462 Young Open 6 Weeks Tibial 
40 1462 Young Control 6 Weeks Patellar 
41 1462 Young Control 6 Weeks Medial 
42 1462 Young Control 6 Weeks Tibial 
43 463 Young Open 12 Weeks Patellar 
44 463 Young Open 12 Weeks Medial 
45 463 Young Open 12 Weeks Tibial 
46 463 Young Control  12 Weeks Patellar 
47 463 Young Control  12 Weeks Medial 
48 463 Young Control  12 Weeks Tibial 
49 464 Young Open 12 Weeks Patellar 
50 464 Young Open 12 Weeks Medial 
51 464 Young Open 12 Weeks Tibial 
52 464 Young Control  12 Weeks Patellar 
53 464 Young Control  12 Weeks Medial 
54 464 Young Control  12 Weeks Tibial 
55 465 Young Control  12 Weeks Patellar 
56 465 Young Control  12 Weeks Medial 
57 465 Young Control  12 Weeks Tibial 
58 465 Young Open 12 Weeks Patellar 
59 465 Young Open 12 Weeks Medial 
60 465 Young Open 12 Weeks Tibial 
61 493 Old Open 12 Weeks Patellar 
62 493 Old Open 12 Weeks Medial 
63 493 Old Open 12 Weeks Tibial 
64 493 Old Control  12 Weeks Patellar 
65 493 Old Control  12 Weeks Medial 
66 493 Old Control  12 Weeks Tibial 
67 494 Old Control  12 Weeks Patellar 
68 494 Old Control  12 Weeks Medial 
69 494 Old Control  12 Weeks Tibial 
70 494 Old Open 12 Weeks Patellar 
71 494 Old Open 12 Weeks Medial 
72 494 Old Open 12 Weeks Tibial 
73 498 Old Open 12 Weeks Patellar 
74 498 Old Open 12 Weeks Medial 
75 498 Old Open 12 Weeks Tibial 
76 498 Old Control  12 Weeks Patellar 
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77 498 Old Control  12 Weeks Medial 
78 498 Old Control  12 Weeks Tibial 
79 499 Old Open 12 Weeks Patellar 
80 499 Old Open 12 Weeks Medial 
81 499 Old Open 12 Weeks Tibial 
82 499 Old Control  12 Weeks Patellar 
83 499 Old Control  12 Weeks Medial 
84 499 Old Control  12 Weeks Tibial 
85 500 Old Control  12 Weeks Patellar 
86 500 Old Control  12 Weeks Medial 
87 500 Old Control  12 Weeks Tibial 
88 500 Old Open 12 Weeks Patellar 
89 500 Old Open 12 Weeks Medial 
90 500 Old Open 12 Weeks Tibial 
91 414 Young Control 26 Weeks Patellar 
92 414 Young Control 26 Weeks Medial 
93 414 Young Control 26 Weeks Tibial 
94 414 Young Open 26 Weeks Patellar 
95 414 Young Open 26 Weeks Tibial 
96 415 Young Open 26 Weeks Patellar 
97 415 Young Open 26 Weeks Tibial 
98 415 Young Control 26 Weeks Patellar 
99 415 Young Control 26 Weeks Medial 
100 415 Young Control 26 Weeks Tibial 
101 418 Young Open 26 Weeks Patellar 
102 418 Young Open 26 Weeks Tibial 
103 418 Young Control 26 Weeks Patellar 
104 418 Young Control 26 Weeks Medial 
105 418 Young Control 26 Weeks Tibial 
106 420 Young Control 26 Weeks Patellar 
107 420 Young Control 26 Weeks Medial 
108 420 Young Control 26 Weeks Tibial 
109 420 Young Open 26 Weeks Patellar 
110 420 Young Open 26 Weeks Medial 
111 420 Young Open 26 Weeks Tibial 
112 422 Young Open 26 Weeks Patellar 
113 422 Young Open 26 Weeks Medial 
114 422 Young Open 26 Weeks Tibial 
115 422 Young Control 26 Weeks Patellar 
116 422 Young Control 26 Weeks Medial 
117 422 Young Control 26 Weeks Tibial 
118 450 Young Control 26 Weeks Patellar 
119 450 Young Control 26 Weeks Medial 
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120 450 Young Control 26 Weeks Tibial 
121 450 Young Open 26 Weeks Patellar 
122 450 Young Open 26 Weeks Tibial 
123 477 Old Control 26 Weeks Patellar 
124 477 Old Control 26 Weeks Medial 
125 477 Old Control 26 Weeks Tibial 
126 477 Old Open 26 Weeks Patellar 
127 477 Old Open 26 Weeks Tibial 
128 483 Old Control 26 Weeks Patellar 
129 483 Old Control 26 Weeks Medial 
130 483 Old Control 26 Weeks Tibial 
131 483 Old Open 26 Weeks Patellar 





APPENDIX II  
List of materials used 
1. Reagents and chemicals: 
S.No Name Company Catalogue No. 
1 Acetic acid Fisher Scientific UN2789 
2 Porcine Pepsin Sigma Chemical Company P-7012 
3 EDTA Invitrogen Corporation 15575-038 
4 Na2HPO4 Sigma Chemical Company S-0876 
5 NaCl Fisher Scientific M-11624 
6 Trizma HCL Sigma Chemical Company T-3253 
7 Tris Base Sigma Chemical Company T01503 
8 Glycine Research Products International Corp. G36050-5000 
9 Methanol Fisher Scientific A452-4 
10 Tween 20 Sigma Chemical Company P-9416 
11 SDS Bio-Rad Laboratories Inc.   161-0302 
12 Blotting Grade Blocker 
Non-fat dry milk 
Bio-Rad Laboratories Inc.   170-6404 
13 Bradford reagent Bio-Rad Laboratories Inc.   500-0006 
 
2. Electrophoresis materials: 
S.No Name Company Catalogue No. 
1 Criterion Tris HCL 10% – 20% 
precast gels 
Bio-Rad Laboratories Inc. 345-0042 
2 Laemmli sample buffer Bio-Rad Laboratories Inc. 161-0737 
3 Precision Plus Protein Dual Xtra 
Standards 
Bio-Rad Laboratories Inc. 161-0377 
 
3. Western Blot materials: 
S.No Name Company Catalogue No. 
1 Immun-Blot PVDF Membrane 
Sandwiches 
Bio-Rad Laboratories Inc. 162-0239 
2 Collagen I Antibody Abcam Inc. AB6308 
3 Collagen III Antibody Novus Biologicals NB600-594 
4 Collagen V Antibody Novus Biologicals NBP1-05118 
5 Actin Antibody Santa Cruz Biotechnology H-300 
6 Secondary Anti-Rabbit Antibody  Thermo Scientific 32260 
7 Secondary Anti-Mouse Antibody Pierce 31430 




Total Collagen Concentrations of samples 
Sample Label OD Values Mean Total Collagen Conc. per 10ul 
1 0.134 0.176 
2 0.131 -0.047 
3 0.136 0.291 
4 0.149 1.188 
5 0.145 0.925 
6 0.141 0.682 
7 0.141 0.628 
8 0.145 0.904 
9 0.137 0.372 
10 0.136 0.324 
11 0.135 0.25 
12 0.137 0.385 
13 0.136 0.331 
14 0.142 0.702 
15 0.143 0.763 
16 0.139 0.533 
17 0.145 0.945 
18 0.143 0.823 
19 0.142 0.749 
20 0.147 1.087 
21 0.14 0.594 
22 0.14 0.621 
23 0.141 0.648 
24 0.134 0.183 
25 0.135 0.237 
26 0.138 0.432 
27 0.136 0.351 
28 0.148 1.107 
29 0.147 1.046 
30 0.147 1.06 
31 0.134 0.189 
32 0.136 0.338 
33 0.14 0.587 
34 0.138 0.439 
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35 0.153 1.437 
36 0.142 0.743 
37 0.141 0.675 
38 0.159 1.883 
39 0.156 1.64 
40 0.157 1.721 
41 0.147 1.06 
42 0.152 1.41 
43 0.151 1.019 
44 0.164 1.944 
45 0.173 2.575 
46 0.144 0.553 
47 0.142 0.395 
48 0.147 0.747 
49 0.145 0.611 
50 0.213 5.442 
51 0.159 1.614 
52 0.139 0.173 
53 0.137 0.051 
54 0.157 1.442 
55 0.145 0.582 
56 0.14 0.216 
57 0.163 1.901 
58 0.167 2.152 
59 0.171 2.438 
60 0.151 1.041 
61 0.183 3.292 
62 0.273 9.736 
63 0.173 2.596 
64 0.144 0.524 
65 0.14 0.209 
66 0.138 0.123 
67 0.134 -0.207 
68 0.138 0.109 
69 0.138 0.123 
70 0.158 1.492 
71 0.153 1.141 
72 0.152 1.076 
73 0.159 1.571 
74 0.167 2.173 
75 0.171 2.446 
76 0.139 0.173 
77 0.143 0.424 
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78 0.141 0.317 
79 0.168 2.238 
80 0.158 1.499 
81 0.227 6.474 
82 0.144 0.496 
83 0.147 0.711 
84 0.139 0.18 
85 0.137 0.008 
86 0.146 0.661 
87 0.14 0.209 
88 0.163 1.858 
89 0.159 1.6 
90 0.163 1.908 
91 0.138 0.032 
92 0.143 0.548 
93 0.149 1.174 
94 0.148 1.055 
95 0.158 1.988 
96 0.154 1.591 
97 0.153 1.521 
98 0.143 0.548 
99 0.141 0.32 
100 0.146 0.836 
101 0.157 1.948 
102 0.161 2.315 
103 0.153 1.491 
104 0.148 1.015 
105 0.155 1.7 
106 0.142 0.409 
107 0.142 0.39 
108 0.15 1.243 
109 0.158 2.017 
110 0.156 1.829 
111 0.162 2.395 
112 0.161 2.335 
113 0.153 1.571 
114 0.147 0.926 
115 0.153 1.491 
116 0.148 0.995 
117 0.172 3.457 
118 0.159 2.087 
119 0.17 3.238 
120 0.18 4.191 
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121 0.153 1.511 
122 0.156 1.819 
123 0.151 1.342 
124 0.143 0.519 
125 0.153 1.561 
126 0.158 1.998 
127 0.157 1.888 
128 0.142 0.419 
129 0.142 0.479 
130 0.143 0.509 
131 0.195 5.66 






Densitometry Quantification Values 
Sample Label ACTIN COL I COL III COL V 
1 -479,898.67 -614,845.33 -74,869.33 -717,418.67 
2 732,018.67 1,582,209.33 1,223,349.33 764,072.00 
3 502,436.00 995,394.67 695,893.33 409,178.67 
4 591,066.67 920,205.33 672,148.00 556,558.67 
5 619,454.67 1,051,217.33 797,745.33 514,154.67 
6 734,448.00 1,767,666.67 639,794.67 500,126.67 
7 764,940.00 1,461,802.67 450,400.00 268,110.67 
8 723,325.33 848,446.67 284,933.33 339,049.33 
9 1,068,222.67 1,320,400.00 734,925.33 524,322.67 
10 788,930.67 1,307,800.00 559,092.00 545,638.67 
11 598,642.67 591,976.00 297,876.00 205,881.33 
12 176,806.67 666,669.33 404,872.00 211,492.00 
13 72,685.33 2,250,842.67 993,874.67 -26,989.33 
14 281,190.67 1,022,113.33 184,528.00 263,616.00 
15 470,594.67 945,352.00 433,381.33 131,094.67 
16 698,748.00 1,475,080.00 457,993.33 630,300.00 
17 848,241.33 981,153.33 655,990.67 427,742.67 
18 882,893.33 1,278,706.67 596,148.00 353,409.33 
19 1,019,622.67 2,048,338.67 510,689.33 684,772.00 
20 1,020,274.67 1,938,053.33 685,738.67 506,917.33 
21 743,868.00 1,955,786.67 771,278.67 127,794.00 
22 788,637.33 1,803,237.33 335,484.00 436,545.33 
23 644,576.00 1,514,141.33 538,033.33 277,937.33 
24 -119,894.67 87,377.33 -48,608.00 -518,360.00 
25 895,873.33 796,856.00 999,769.33 149,277.33 
26 444,142.67 1,393,194.67 254,409.33 223,496.00 
27 961,374.67 2,050,598.67 1,091,230.67 450,430.67 
28 1,293,518.67 1,344,437.33 824,404.00 369,656.00 
29 880,297.33 1,688,036.00 1,273,477.33 345,576.00 
30 497,677.33 1,440,144.00 906,181.33 395,012.00 
31 498,682.67 1,820,068.00 988,230.67 318,761.33 
32 83,310.67 533,480.00 320,657.33 -24,864.00 
33 238,602.67 1,216,754.67 695,549.33 187,822.67 
34 637,669.33 2,319,844.00 1,136,393.33 448,305.33 
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35 605,316.00 2,470,000.00 1,242,009.33 303,872.00 
36 778,934.67 2,111,405.33 1,459,225.33 2,549.33 
37 568,757.33 1,209,946.67 1,000,048.00 115,901.33 
38 594,350.67 1,413,241.33 1,066,154.67 385,169.33 
39 374,688.00 1,706,170.67 727,596.00 428,244.00 
40 19,389.33 184,454.67 41,277.33 84,585.33 
41 30,918.67 191,125.33 -16,724.00 24,408.00 
42 493,681.33 1,204,692.00 624,066.67 323,928.33 
43 593,570.67 1,955,188.00 1,049,098.67 251,828.00 
44 705,880.00 2,346,084.00 1,278,106.67 607,472.00 
45 690,560.00 1,941,204.00 930,345.33 345,142.67 
46 104,302.67 312,274.67 169,325.33 165,172.33 
47 476,956.00 709,697.33 712,568.00 244,754.67 
48 481,100.00 773,200.00 645,482.67 117,390.67 
49 412,437.33 964,509.33 2,080,028.00 901,021.33 
50 333,142.67 841,190.67 741,396.00 859,822.67 
51 355,241.33 614,588.00 573,688.00 879,282.67 
52 366,949.33 810,804.00 803,648.00 1,177,933.33 
53 160,104.00 282,225.33 361,226.67 675,268.00 
54 424,205.33 699,294.67 757,453.33 1,383,376.00 
55 352,589.33 590,918.67 879,420.00 944,377.33 
56 356,901.33 571,018.67 955,674.67 1,120,698.67 
57 550,130.67 662,502.67 879,677.33 1,011,652.00 
58 596,693.33 786,560.00 911,229.33 1,266,993.33 
59 346,914.67 615,354.67 837,569.33 1,033,609.33 
60 216,313.33 679,353.33 738,176.00 747,062.67 
61 602,085.33 889,045.33 1,838,580.00 1,522,478.33 
62 621,880.00 1,172,806.67 1,486,442.67 2,164,034.00 
63 353,633.33 594,180.00 1,065,497.33 1,213,718.67 
64 340,757.33 726,554.67 773,096.00 835,804.00 
65 314,620.00 372,201.33 539,268.00 781,648.00 
66 416,060.00 659,478.67 787,597.33 1,439,678.67 
67 99,805.33 348,465.33 470,077.33 428,809.33 
68 199,852.00 476,038.67 499,706.67 676,273.33 
69 231,038.67 470,862.67 699,294.67 637,046.67 
70 490,637.33 968,482.67 1,429,218.67 1,239,568.00 
71 448,750.67 1,017,349.33 1,662,010.67 1,373,232.00 
72 185,124.00 673,529.33 1,058,454.67 1,050,982.67 
73 184,881.33 515,958.67 1,639,158.67 1,084,376.33 
74 474,854.67 1,266,912.00 1,418,766.67 1,309,736.00 
75 342,074.67 1,241,704.00 1,581,102.67 1,160,968.00 
76 431,344.00 658,188.00 550,530.67 1,009,850.67 
77 399,776.00 841,102.67 669,686.67 1,139,548.00 
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78 347,610.67 740,664.00 520,944.00 1,059,052.00 
79 475,049.33 1,210,141.33 757,653.33 1,531,792.00 
80 474,489.33 1,372,222.67 715,718.67 1,726,925.33 
81 520,229.33 2,238,320.00 1,028,677.33 1,992,462.67 
82 380,702.67 892,809.33 614,917.33 1,228,994.67 
83 276,004.00 696,708.00 603,816.00 1,419,170.67 
84 242,948.00 748,428.00 359,577.33 1,405,902.67 
85 300,182.67 515,129.33 1,191,237.33 39,438.67 
86 243,429.33 314,212.00 644,976.00 379,882.67 
87 453,974.67 882,096.00 1,280,277.33 835,405.33 
88 374,288.00 850,237.33 1,297,482.67 879,418.67 
89 253,616.00 382,762.67 690,326.67 859,348.00 
90 511,122.67 669,768.00 845,366.67 1,021,469.33 
91 184,832.00 313,162.67 483,516.00 775,992.00 
92 383,376.00 519,112.00 724,592.00 914,474.67 
93 337,624.00 515,928.00 619,768.00 993,752.00 
94 430,210.67 662,454.67 749,334.67 1,002,048.00 
95 484,494.67 784,158.67 691,194.67 924,609.33 
96 357,064.00 789,753.33 23,413.33 676,352.00 
97 2,306,412.00 969,738.67 2,354,344.00 902,549.33 
98 636,834.67 407,176.00 1,112,781.33 417,409.33 
99 1,196,380.00 393,486.67 1,067,649.33 601,229.33 
100 1,675,602.67 841,934.67 1,381,625.33 805,058.67 
101 1,955,074.67 996,889.33 1,728,340.00 997,788.00 
102 1,392,437.33 1,439,692.00 1,576,070.67 980,670.67 
103 387,122.67 445,612.00 691,088.00 522,992.00 
104 829,938.67 556,756.00 519,668.00 430,788.00 
105 1,182,552.00 867,428.00 1,421,660.00 625,093.33 
106 1,160,841.33 1,259,949.33 1,571,598.67 822,264.00 
107 1,039,345.33 718,858.67 1,256,080.00 628,196.00 
108 1,091,746.67 605,468.00 1,708,868.00 461,900.00 
109 1,253,406.67 569,529.33 1,263,438.67 544,442.67 
110 1,370,204.00 1,218,300.00 769,472.00 859,552.00 
111 1,138,882.67 912,070.67 536,829.33 793,580.00 
112 1,013,766.67 1,029,568.00 652,676.00 748,730.67 
113 792,741.33 716,186.67 491,389.33 531,004.00 
114 1,052,257.33 869,094.67 544,482.67 560,133.33 
115 685,122.67 319,389.33 690,749.33 227,941.33 
116 603,362.67 384,929.33 350,424.00 234,061.33 
117 660,601.33 403,282.67 975,932.00 383,089.33 
118 1,092,217.33 1,022,422.67 804,968.00 593,012.00 
119 976,196.00 801,512.00 660,289.33 731,285.33 
120 966,776.00 638,740.00 625,601.33 724,797.33 
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121 548,641.33 265,210.67 496,337.33 101,509.33 
122 666,249.33 727,714.67 873,988.00 125,300.00 
123 198,389.33 183,738.67 372,892.00 70,521.33 
124 498,837.33 812,222.67 666,896.00 206,165.33 
125 249,234.67 331,998.67 556,142.67 39,616.00 
126 552,281.33 1,234,245.33 1,135,684.00 418,456.00 
127 600,849.33 1,382,412.00 1,407,977.33 727,977.33 
128 594,008.00 964,920.00 1,043,028.00 366,898.67 
129 484,461.33 707,130.67 724,502.67 215,022.67 
130 668,458.67 1,179,816.00 1,112,232.00 388,957.33 
131 39,765.33 59,388.00 75,598.67 -101,193.33 








Normalized Collagen Values 
Sample Label Normalized COL 1 Normalized COL III Normalized COL V 
1 1.281198 0.156011 1.494938 
2 2.161433 1.6712 1.043788 
3 1.981137 1.385039 0.81439 
4 1.556855 1.137178 0.941617 
5 1.697004 1.287819 0.830012 
6 2.406796 0.871123 0.680956 
7 1.911003 0.588804 0.350499 
8 1.172981 0.393921 0.468737 
9 1.236072 0.687989 0.490836 
10 1.657687 0.708671 0.691618 
11 0.988864 0.497586 0.343914 
12 3.770612 2.289914 1.196177 
13 30.96695 13.67366 -0.37132 
14 3.634948 0.656238 0.937499 
15 2.008846 0.920923 0.278572 
16 2.111033 0.655449 0.902042 
17 1.156691 0.773354 0.50427 
18 1.448314 0.675221 0.400285 
19 2.008918 0.500861 0.671594 
20 1.899541 0.672112 0.496844 
21 2.629212 1.036849 0.171797 
22 2.286523 0.425397 0.553544 
23 2.34905 0.834709 0.431194 
24 -0.72878 0.405423 4.323462 
25 0.889474 1.115972 0.166628 
26 3.136818 0.57281 0.503208 
27 2.132986 1.135073 0.468528 
28 1.039364 0.637334 0.285776 
29 1.917575 1.446645 0.392567 
30 2.89373 1.820821 0.793711 
31 3.649752 1.981682 0.639207 
32 6.403501 3.848935 -0.29845 
33 5.099501 2.915094 0.787178 
34 3.638005 1.782104 0.703037 
44 
 
35 4.080513 2.051836 0.502006 
36 2.710632 1.87336 0.003273 
37 2.127351 1.758303 0.20378 
38 2.37779 1.793814 0.648051 
39 4.553577 1.941872 1.142935 
40 9.513205 2.128868 4.362468 
41 6.181551 -0.5409 0.789426 
42 2.440222 1.264108 0.656149 
43 3.293943 1.767437 0.42426 
44 3.32363 1.810657 0.860588 
45 2.811058 1.347233 0.499801 
46 2.993928 1.623404 1.583587 
47 1.487972 1.493991 0.51316 
48 1.60715 1.341681 0.244005 
49 2.33856 5.043258 2.184626 
50 2.525016 2.225461 2.580944 
51 1.730058 1.614925 2.47517 
52 2.20958 2.190079 3.210071 
53 1.762763 2.2562 4.217684 
54 1.648482 1.785582 3.2611 
55 1.67594 2.494176 2.678406 
56 1.599934 2.6777 3.14008 
57 1.204264 1.599033 1.83893 
58 1.318198 1.527132 2.123358 
59 1.773793 2.414338 2.979434 
60 3.140599 3.412531 3.453614 
61 1.47661 3.053687 2.528675 
62 1.885905 2.39024 3.479826 
63 1.680215 3.013 3.432139 
64 2.132176 2.268758 2.452784 
65 1.183019 1.71403 2.484419 
66 1.585057 1.89299 3.460267 
67 3.49145 4.709942 4.296457 
68 2.381956 2.500384 3.383871 
69 2.038025 3.026743 2.757316 
70 1.973928 2.912984 2.526445 
71 2.26707 3.703639 3.060122 
72 3.63826 5.717544 5.677182 
73 2.790756 8.866004 5.865256 
74 2.667999 2.987791 2.758183 
75 3.629921 4.622098 3.393902 
76 1.5259 1.276315 2.341172 
77 2.103935 1.675155 2.850466 
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78 2.130729 1.498642 3.046661 
79 2.547401 1.594894 3.22449 
80 2.891999 1.508398 3.639545 
81 4.302564 1.977354 3.82997 
82 2.345162 1.615217 3.228227 
83 2.524268 2.187707 5.141848 
84 3.08061 1.480059 5.786846 
85 1.716053 3.968375 0.131382 
86 1.290773 2.649541 1.560546 
87 1.943051 2.820151 1.840203 
88 2.271613 3.466536 2.349578 
89 1.509221 2.721937 3.388382 
90 1.310386 1.653941 1.998482 
91 1.69431 2.615976 4.198364 
92 1.354055 1.89003 2.385321 
93 1.528114 1.835675 2.943369 
94 1.539838 1.741785 2.329203 
95 1.618508 1.42663 1.908399 
96 2.211798 0.065572 1.894204 
97 0.420453 1.020782 0.391322 
98 0.639375 1.747363 0.655444 
99 0.328898 0.8924 0.50254 
100 0.502467 0.824554 0.480459 
101 0.509898 0.884028 0.510358 
102 1.033937 1.131879 0.704284 
103 1.151087 1.785191 1.350972 
104 0.67084 0.626152 0.51906 
105 0.733522 1.202197 0.528597 
106 1.085376 1.353845 0.708335 
107 0.691646 1.20853 0.604415 
108 0.554587 1.565261 0.423083 
109 0.454385 1.008004 0.43437 
110 0.889138 0.561575 0.627317 
111 0.800847 0.471365 0.696806 
112 1.015587 0.643813 0.738563 
113 0.90343 0.619861 0.669833 
114 0.825934 0.517443 0.532316 
115 0.466178 1.008213 0.332701 
116 0.637973 0.580785 0.387928 
117 0.610478 1.477339 0.57991 
118 0.936098 0.737004 0.542943 
119 0.821056 0.67639 0.749117 
120 0.660691 0.647101 0.749706 
46 
 
121 0.483395 0.904666 0.185019 
122 1.092256 1.311803 0.188068 
123 0.926152 1.879597 0.355469 
124 1.628232 1.336901 0.413292 
125 1.332073 2.231402 0.158951 
126 2.234813 2.056351 0.757686 
127 2.300763 2.343312 1.21158 
128 1.624423 1.755916 0.617666 
129 1.459623 1.495481 0.443839 
130 1.76498 1.663875 0.581872 
131 1.493462 1.90112 -2.54476 
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